Ulipristal acetate (UPA) is a newly developed emergency contraceptive currently available in the USA and Europe. It is approved as a 30 mg one-time dose taken within 120 h (5 days) of unprotected intercourse or failed contraception. This selective progesterone receptor modulator appears to be more effective than the levonorgestrel-containing emergency contraceptive, which must be taken within 72 h of unprotected intercourse. According to pharmacodynamic trials, UPA delays follicular maturation and ovulation. In addition, UPA may modulate the endometrium. Both Phase III clinical trials found that UPA does not lose efficacy within the 120-h dosing interval. Throughout all phases of clinical studies, UPA was shown to be well tolerated with only minimal adverse drug reactions, all of which are similar to competitor therapies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1586/ecp.11.21 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Over-the-counter procured emergency contraception among undergraduate students in a public University in Ghana.
Contracept Reprod Med
December 2024
Faculty of Science Education, Department of Health Administration and Education, University of Education, P.O Box 25, Winneba, Central Region, West African, Ghana.
Background: Emergency Contraception (EC) is more popular among young people today, yet, there is little research on Over-the-counter procured EC among undergraduate students in African universities. This study's primary goal is to fill that gap.
Methods: This was an exploratory-cross-sequential study conducted in a public university in Ghana, using 145 purposively sampled sexually active undergraduate students.
Changes in provision of extended community pharmacy services in Aotearoa New Zealand, 2018 to 2022.
BMC Health Serv Res
December 2024
Department of Primary Health Care & General Practice, Te Tari Hauora Tūmatanui, University of Otago Wellington, PO Box 7343, Wellington, 6242, New Zealand.
Background: Recognition is growing of the contributions community pharmacists make to the primary health care team, as their role shifts from a traditional dispensing focus to greater emphasis on fully applying their clinical skills. Some extended pharmacist services (e.g.
View Article and Find Full Text PDFEmergency contraceptive pill awareness in Bangladesh: missed opportunities in antenatal care and family welfare assistant visits.
Reprod Health
December 2024
International Center for Diarrhoeal Disease and Research, Bangladesh, icddr,b, GPO Box 128, Dhaka, 1000, Bangladesh.
Background: Despite high coverage of antenatal care (ANC) and family welfare assistant (FWA) visits, emergency contraceptive pill (ECP) awareness is critically low in Bangladesh. We aim to investigate the missed opportunities in generating ECP awareness through ANC and FWA visit programs; and assess the missed opportunities and sociodemographic discrimination in receiving family planning (FP) counseling during ANC.
Methods: We used data from the nationwide Bangladesh Demographic and Health Survey 2017-18.
Changes in Reproductive Health Information-Seeking Behaviors After the Dobbs Decision: Systematic Search of the Wikimedia Database.
JMIR Infodemiology
December 2024
Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St Louis, MO, United States.
Background: After the US Supreme Court overturned Roe v. Wade, confusion followed regarding the legality of abortion in different states across the country. Recent studies found increased Google searches for abortion-related terms in restricted states after the Dobbsv.
View Article and Find Full Text PDFContraception Use in Cancer Survivors, Clinical Practice and Patients' Preferences.
Open Access J Contracept
December 2024
IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Current literature suggests that emergency contraception, defined as a therapy aimed at preventing an unwanted pregnancy after unprotected or insufficiently protected intercourse, is used more by cancer survivors than by the general population. This may be related to reduced use of contraception in women after cancer diagnosis and, when it is used, to a choice of less effective methods, even in the absence of contraindications to hormonal options. The purpose of this review is to analyze the use of contraception in these patients, its predictors and the preferred methods, as well as to try to define timing and characteristics of an effective contraception counseling.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!